| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.941 | 0.003 | 0.941 | Antioxidant | 0.755 0.005 DBMET01434 | ||
| 0.821 | 0.002 | 0.821 | Dual specificity phosphatase 3 inhibitor | 0.798 0.002 DBMET01434 | ||
| 0.817 | 0.002 | 0.817 | Dual specificity phosphatase inhibitor | 0.792 0.002 DBMET01434 | ||
| 0.776 | 0.004 | 0.776 | Angiogenesis stimulant | 0.704 0.005 DBMET01434 | ||
| 0.76 | 0.005 | 0.91 | Amyloid beta aggregation inhibitor | 0.91 0.004 DBMET01434 | DBMET01434 | |
| 0.748 | 0.002 | 0.96 | Uric acid excretion stimulant | 0.96 0 DBMET01434 | DBMET01434 | |
| 0.721 | 0.011 | 0.721 | 15-Lipoxygenase inhibitor | 0.479 0.045 DBMET01434 | ||
| 0.711 | 0.003 | 0.734 | Amyloid beta precursor protein antagonist | 0.734 0.003 DBMET01434 | DBMET01434 | |
| 0.703 | 0.003 | 0.703 | Peroxidase inhibitor | 0.516 0.008 DBMET01434 | ||
| 0.673 | 0.002 | 0.673 | Glutamate dehydrogenase inhibitor | 0.5 0.003 DBMET01434 | ||
| 0.652 | 0.002 | 0.652 | Expectorant | 0.435 0.004 DBMET01434 | ||
| 0.636 | 0.002 | 0.636 | Mucolytic | 0.416 0.003 DBMET01434 | ||
| 0.616 | 0.002 | 0.616 | Neutral endopeptidase inhibitor | 0.235 0.003 DBMET01434 | ||
| 0.618 | 0.004 | 0.725 | Protein-tyrosine phosphatase inhibitor | 0.725 0.003 DBMET01434 | DBMET01434 | |
| 0.615 | 0.004 | 0.615 | Chelator | 0.504 0.005 DBMET01434 | ||
| 0.608 | 0.018 | 0.608 | Aldehyde oxidase inhibitor | 0.351 0.055 DBMET01434 | ||
| 0.584 | 0.013 | 0.584 | Interleukin antagonist | |||
| 0.533 | 0.003 | 0.533 | Leukotriene A4 hydrolase inhibitor | 0.067 0.013 DBMET01434 | ||
| 0.528 | 0.003 | 0.556 | Sodium/bile acid cotransporter inhibitor | 0.556 0.002 DBMET01434 | DBMET01434 | |
| 0.539 | 0.027 | 0.664 | Cholesterol antagonist | 0.664 0.011 DBMET01434 | DBMET01434 | |
| 0.483 | 0.003 | 0.483 | Succinate dehydrogenase inhibitor | 0.356 0.005 DBMET01434 | ||
| 0.5 | 0.02 | 0.63 | Apoptosis antagonist | 0.63 0.007 DBMET01434 | DBMET01434 | |
| 0.465 | 0.005 | 0.597 | p38 MAP kinase inhibitor | 0.597 0.004 DBMET01434 | DBMET01434 | |
| 0.471 | 0.016 | 0.471 | Superoxide dismutase inhibitor | 0.394 0.028 DBMET01434 | ||
| 0.46 | 0.009 | 0.46 | Diuretic | 0.28 0.026 DBMET01434 | ||
| 0.467 | 0.016 | 0.467 | DNA synthesis inhibitor | 0.413 0.02 DBMET01434 | ||
| 0.454 | 0.009 | 0.603 | Hepatoprotectant | 0.603 0.005 DBMET01434 | DBMET01434 | |
| 0.416 | 0.003 | 0.437 | CDC25A inhibitor | 0.437 0.003 DBMET01434 | DBMET01434 | |
| 0.402 | 0.003 | 0.402 | Phenylalanine 4-hydroxylase inhibitor | 0.175 0.009 DBMET01434 | ||
| 0.384 | 0.003 | 0.469 | GABA C receptor antagonist | 0.469 0.003 DBMET01434 | DBMET01434 | |
| 0.386 | 0.011 | 0.386 | Phospholipase C inhibitor | 0.205 0.041 DBMET01434 | ||
| 0.363 | 0.004 | 0.363 | Adenylate kinase inhibitor | 0.325 0.005 DBMET01434 | ||
| 0.365 | 0.01 | 0.786 | NOS3 expression enhancer | 0.786 0.002 DBMET01434 | DBMET01434 | |
| 0.349 | 0.003 | 0.349 | Angiotensin-converting enzyme inhibitor | 0.061 0.029 DBMET01434 | ||
| 0.347 | 0.004 | 0.483 | Creatine kinase inhibitor | 0.483 0.002 DBMET01434 | DBMET01434 | |
| 0.345 | 0.003 | 0.44 | Thioredoxin inhibitor | 0.44 0.001 DBMET01434 | DBMET01434 | |
| 0.411 | 0.072 | 0.449 | Antibacterial | 0.449 0.057 DBMET01434 | DBMET01434 | |
| 0.343 | 0.004 | 0.343 | Alcohol dehydrogenase inhibitor | 0.15 0.02 DBMET01434 | ||
| 0.342 | 0.005 | 0.342 | Porphobilinogen synthase inhibitor | 0.268 0.006 DBMET01434 | ||
| 0.339 | 0.004 | 0.398 | Farnesoid X receptor antagonist | 0.398 0.004 DBMET01434 | DBMET01434 | |
| 0.337 | 0.004 | 0.425 | Carbamoyl phosphate synthetase inhibitor | 0.425 0.003 DBMET01434 | DBMET01434 | |
| 0.328 | 0.009 | 0.541 | Protein-tyrosine phosphatase 1B inhibitor | 0.541 0.004 DBMET01434 | DBMET01434 | |
| 0.376 | 0.057 | 0.419 | Immunostimulant | 0.419 0.044 DBMET01434 | DBMET01434 | |
| 0.331 | 0.047 | 0.452 | DNA damaging | 0.452 0.019 DBMET01434 | DBMET01434 | |
| 0.326 | 0.044 | 0.481 | Antiamyloidogenic | 0.481 0.018 DBMET01434 | DBMET01434 | |
| 0.321 | 0.047 | 0.321 | Insulysin inhibitor | 0.253 0.093 DBMET01434 | ||
| 0.273 | 0.004 | 0.273 | Glutamate decarboxylase inhibitor | 0.178 0.009 DBMET01434 | ||
| 0.28 | 0.014 | 0.552 | Alkylator | 0.552 0.004 DBMET01434 | DBMET01434 | |
| 0.273 | 0.011 | 0.273 | Aminopeptidase B inhibitor | 0.214 0.018 DBMET01434 | ||
| 0.308 | 0.05 | 0.308 | Free radical scavenger | 0.211 0.089 DBMET01434 | ||
| 0.313 | 0.065 | 0.313 | Lipoxygenase inhibitor | |||
| 0.275 | 0.028 | 0.275 | Thrombolytic | 0.119 0.111 DBMET01434 | ||
| 0.247 | 0.004 | 0.247 | NMDA receptor agonist | 0.211 0.004 DBMET01434 | ||
| 0.247 | 0.008 | 0.247 | Phosphofructokinase-1 inhibitor | 0.215 0.01 DBMET01434 | ||
| 0.235 | 0.006 | 0.235 | Ornithine carbamoyltransferase inhibitor | 0.187 0.007 DBMET01434 | ||
| 0.267 | 0.04 | 0.347 | DNA methyltransferase I inhibitor | 0.347 0.014 DBMET01434 | DBMET01434 | |
| 0.236 | 0.01 | 0.279 | Beta amyloid protein antagonist | 0.279 0.007 DBMET01434 | DBMET01434 | |
| 0.25 | 0.027 | 0.387 | Lipid peroxidase inhibitor | 0.387 0.01 DBMET01434 | DBMET01434 | |
| 0.223 | 0.004 | 0.242 | Aminopeptidase microsomal inhibitor | 0.242 0.003 DBMET01434 | DBMET01434 | |
| 0.233 | 0.017 | 0.233 | Mannose-6-phosphate isomerase inhibitor | 0.162 0.055 DBMET01434 | ||
| 0.267 | 0.05 | 0.267 | Calpain inhibitor | 0.226 0.089 DBMET01434 | ||
| 0.224 | 0.011 | 0.224 | Catalase inhibitor | 0.152 0.026 DBMET01434 | ||
| 0.212 | 0.003 | 0.212 | Vanilloid 2 antagonist | |||
| 0.22 | 0.017 | 0.233 | Arachidonic acid antagonist | 0.233 0.01 DBMET01434 | DBMET01434 | |
| 0.264 | 0.064 | 0.305 | Gastrin inhibitor | 0.305 0.03 DBMET01434 | DBMET01434 | |
| 0.225 | 0.025 | 0.225 | Alkaline phosphatase inhibitor | 0.112 0.097 DBMET01434 | ||
| 0.199 | 0.003 | 0.199 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.025 0.006 DBMET01434 | ||
| 0.218 | 0.024 | 0.275 | Cell wall synthesis inhibitor | 0.275 0.012 DBMET01434 | DBMET01434 | |
| 0.188 | 0.003 | 0.196 | Squalene synthetase inhibitor | 0.196 0.002 DBMET01434 | DBMET01434 | |
| 0.235 | 0.057 | 0.34 | DNA methylase inhibitor | 0.34 0.018 DBMET01434 | DBMET01434 | |
| 0.204 | 0.031 | 0.243 | Hemostatic | 0.243 0.023 DBMET01434 | DBMET01434 | |
| 0.177 | 0.005 | 0.22 | Glycine receptor agonist | 0.22 0.004 DBMET01434 | DBMET01434 | |
| 0.173 | 0.004 | 0.189 | Aminopeptidase N inhibitor | 0.189 0.004 DBMET01434 | DBMET01434 | |
| 0.172 | 0.004 | 0.172 | Farnesyltransferase inhibitor | |||
| 0.171 | 0.007 | 0.171 | Endothelin-converting enzyme inhibitor | |||
| 0.229 | 0.065 | 0.229 | RNA-directed DNA polymerase inhibitor | 0.225 0.069 DBMET01434 | ||
| 0.202 | 0.041 | 0.202 | Phospholipase A2 inhibitor | 0.185 0.051 DBMET01434 | ||
| 0.191 | 0.037 | 0.247 | Alpha-N-acetylglucosaminidase inhibitor | 0.247 0.023 DBMET01434 | DBMET01434 | |
| 0.167 | 0.016 | 0.277 | Triose-phosphate isomerase inhibitor | 0.277 0.005 DBMET01434 | DBMET01434 | |
| 0.153 | 0.003 | 0.153 | Phospholipase D inhibitor | 0.121 0.006 DBMET01434 | ||
| 0.171 | 0.023 | 0.171 | Interleukin 8 antagonist | 0.16 0.028 DBMET01434 | ||
| 0.159 | 0.015 | 0.159 | Carbonic anhydrase inhibitor | 0.108 0.024 DBMET01434 | ||
| 0.166 | 0.023 | 0.205 | Photosensitizer | 0.205 0.012 DBMET01434 | DBMET01434 | |
| 0.165 | 0.024 | 0.165 | Carbonic anhydrase III inhibitor | 0.11 0.052 DBMET01434 | ||
| 0.174 | 0.035 | 0.174 | Aldehyde dehydrogenase inhibitor | 0.118 0.073 DBMET01434 | ||
| 0.153 | 0.017 | 0.189 | NADH dehydrogenase inhibitor | 0.189 0.011 DBMET01434 | DBMET01434 | |
| 0.163 | 0.027 | 0.187 | Sphingosine 1-phosphate receptor 2 antagonist | 0.187 0.012 DBMET01434 | DBMET01434 | |
| 0.138 | 0.004 | 0.138 | Mannosidase inhibitor | 0.07 0.011 DBMET01434 | ||
| 0.146 | 0.013 | 0.146 | Carbonic anhydrase XII inhibitor | 0.053 0.036 DBMET01434 | ||
| 0.151 | 0.019 | 0.151 | Histidine decarboxylase inhibitor | 0.069 0.052 DBMET01434 | ||
| 0.144 | 0.013 | 0.144 | Carbonic anhydrase IX inhibitor | 0.097 0.021 DBMET01434 | ||
| 0.201 | 0.08 | 0.201 | Pyruvate kinase inhibitor | |||
| 0.257 | 0.139 | 0.314 | Calcium channel activator | 0.314 0.078 DBMET01434 | DBMET01434 | |
| 0.133 | 0.016 | 0.133 | Aminopeptidase I inhibitor | 0.081 0.041 DBMET01434 | ||
| 0.246 | 0.129 | 0.397 | Antithrombotic | 0.397 0.05 DBMET01434 | DBMET01434 | |
| 0.132 | 0.019 | 0.132 | Carbonic anhydrase V inhibitor | 0.096 0.028 DBMET01434 | ||
| 0.117 | 0.005 | 0.117 | Alpha-mannosidase inhibitor | 0.078 0.012 DBMET01434 | ||
| 0.154 | 0.045 | 0.154 | Monophenol monooxygenase inhibitor | 0.115 0.065 DBMET01434 | ||
| 0.128 | 0.019 | 0.144 | Hematopoietic | 0.144 0.016 DBMET01434 | DBMET01434 | |
| 0.137 | 0.03 | 0.137 | Urease inhibitor | 0.096 0.072 DBMET01434 | ||
| 0.133 | 0.029 | 0.133 | Anabolic | 0.109 0.051 DBMET01434 | ||
| 0.107 | 0.003 | 0.107 | Membrane dipeptidase inhibitor | 0.097 0.004 DBMET01434 | ||
| 0.1 | 0.004 | 0.13 | Purinergic P2Y2 antagonist | 0.13 0.003 DBMET01434 | DBMET01434 | |
| 0.112 | 0.021 | 0.112 | Interferon agonist | 0.111 0.021 DBMET01434 | ||
| 0.112 | 0.022 | 0.132 | HIV-1 integrase (3'-Processing) inhibitor | 0.132 0.016 DBMET01434 | DBMET01434 | |
| 0.132 | 0.042 | 0.173 | GABA C receptor agonist | 0.173 0.026 DBMET01434 | DBMET01434 | |
| 0.109 | 0.021 | 0.109 | Carbonic anhydrase VA inhibitor | 0.084 0.033 DBMET01434 | ||
| 0.121 | 0.039 | 0.121 | HIV-1 integrase (Overall Integration) inhibitor | 0.099 0.056 DBMET01434 | ||
| 0.111 | 0.029 | 0.175 | Inducible nitric-oxide synthase inhibitor | 0.175 0.011 DBMET01434 | DBMET01434 | |
| 0.16 | 0.079 | 0.16 | Neurotensin receptor agonist | 0.147 0.109 DBMET01434 | ||
| 0.112 | 0.032 | 0.112 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.073 0.057 DBMET01434 | ||
| 0.097 | 0.018 | 0.109 | Purinergic P2X1 antagonist | 0.109 0.014 DBMET01434 | DBMET01434 | |
| 0.106 | 0.029 | 0.106 | Metalloproteinase-9 inhibitor | |||
| 0.096 | 0.02 | 0.096 | Carbonic anhydrase II inhibitor | 0.063 0.033 DBMET01434 | ||
| 0.146 | 0.07 | 0.153 | Adenylate cyclase stimulant | 0.153 0.057 DBMET01434 | DBMET01434 | |
| 0.095 | 0.024 | 0.11 | HIV-1 integrase (Strand Transfer) inhibitor | 0.11 0.019 DBMET01434 | DBMET01434 | |
| 0.088 | 0.018 | 0.096 | Interferon inducer | 0.096 0.014 DBMET01434 | DBMET01434 | |
| 0.078 | 0.009 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.104 0.004 DBMET01434 | DBMET01434 | |
| 0.123 | 0.054 | 0.197 | GABA receptor agonist | 0.197 0.018 DBMET01434 | DBMET01434 | |
| 0.077 | 0.008 | 0.214 | Cholecystokinin B agonist | 0.214 0.004 DBMET01434 | DBMET01434 | |
| 0.071 | 0.003 | 0.071 | Aminopeptidase A inhibitor | 0.055 0.003 DBMET01434 | ||
| 0.106 | 0.038 | 0.119 | Bile acid receptor antagonist | 0.119 0.02 DBMET01434 | DBMET01434 | |
| 0.103 | 0.037 | 0.103 | Carbonic anhydrase VI inhibitor | 0.073 0.068 DBMET01434 | ||
| 0.078 | 0.013 | 0.097 | Glutamate (mGluR group III) agonist | 0.097 0.01 DBMET01434 | DBMET01434 | |
| 0.081 | 0.02 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 DBMET01434 | ||
| 0.102 | 0.042 | 0.102 | Phosphodiesterase I inhibitor | 0.093 0.053 DBMET01434 | ||
| 0.081 | 0.022 | 0.081 | Carbonic anhydrase VB inhibitor | 0.056 0.039 DBMET01434 | ||
| 0.074 | 0.018 | 0.082 | Lipocortins synthesis agonist | 0.082 0.012 DBMET01434 | DBMET01434 | |
| 0.129 | 0.075 | 0.129 | Amylase inhibitor | |||
| 0.137 | 0.084 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.054 DBMET01434 | DBMET01434 | |
| 0.056 | 0.006 | 0.115 | Cholecystokinin agonist | 0.115 0.004 DBMET01434 | DBMET01434 | |
| 0.089 | 0.043 | 0.089 | Carbonic anhydrase XIII inhibitor | |||
| 0.116 | 0.071 | 0.212 | DNA polymerase I inhibitor | 0.212 0.024 DBMET01434 | DBMET01434 | |
| 0.063 | 0.019 | 0.063 | Toll-Like receptor 2 agonist | 0.043 0.028 DBMET01434 | ||
| 0.112 | 0.068 | 0.22 | TRPA1 agonist | 0.22 0.008 DBMET01434 | DBMET01434 | |
| 0.06 | 0.017 | 0.061 | Oxytocin agonist | 0.061 0.016 DBMET01434 | DBMET01434 | |
| 0.051 | 0.01 | 0.051 | Peptide deformylase inhibitor | |||
| 0.066 | 0.029 | 0.089 | Acyl-CoA dehydrogenase inhibitor | 0.089 0.019 DBMET01434 | DBMET01434 | |
| 0.098 | 0.063 | 0.196 | UDP-glucose 4-epimerase inhibitor | 0.196 0.019 DBMET01434 | DBMET01434 | |
| 0.17 | 0.135 | 0.188 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.085 DBMET01434 | DBMET01434 | |
| 0.219 | 0.185 | 0.286 | GABA C receptor rho-3 antagonist | 0.286 0.126 DBMET01434 | DBMET01434 | |
| 0.053 | 0.02 | 0.053 | Growth hormone release inhibitor | |||
| 0.078 | 0.046 | 0.093 | GABA B receptor agonist | 0.093 0.023 DBMET01434 | DBMET01434 | |
| 0.048 | 0.017 | 0.057 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.057 0.009 DBMET01434 | DBMET01434 | |
| 0.034 | 0.004 | 0.039 | Follicle-stimulating hormone antagonist | 0.039 0.004 DBMET01434 | DBMET01434 | |
| 0.036 | 0.006 | 0.036 | Geranylgeranyltransferase I inhibitor | |||
| 0.188 | 0.159 | 0.218 | Tyrosine 3 hydroxylase inhibitor | 0.218 0.106 DBMET01434 | DBMET01434 | |
| 0.044 | 0.015 | 0.044 | Histone deacetylase class IV inhibitor | |||
| 0.044 | 0.015 | 0.044 | Histone deacetylase 11 inhibitor | |||
| 0.055 | 0.026 | 0.055 | Adenosine deaminase inhibitor | |||
| 0.041 | 0.013 | 0.041 | Histone deacetylase class IIb inhibitor | |||
| 0.04 | 0.012 | 0.04 | Histone deacetylase 6 inhibitor | |||
| 0.055 | 0.027 | 0.071 | CD45 antagonist | 0.071 0.015 DBMET01434 | DBMET01434 | |
| 0.124 | 0.096 | 0.124 | Cytidine deaminase inhibitor | |||
| 0.042 | 0.015 | 0.045 | Glutamate (mGluR4) agonist | 0.045 0.013 DBMET01434 | DBMET01434 | |
| 0.048 | 0.021 | 0.068 | GABA B receptor antagonist | 0.068 0.009 DBMET01434 | DBMET01434 | |
| 0.056 | 0.031 | 0.065 | Heparanase inhibitor | 0.065 0.016 DBMET01434 | DBMET01434 | |
| 0.033 | 0.008 | 0.033 | Aminopeptidase P inhibitor | |||
| 0.03 | 0.005 | 0.045 | Ileal bile acid transport inhibitor | 0.045 0.004 DBMET01434 | DBMET01434 | |
| 0.094 | 0.07 | 0.153 | Nitric-oxide synthase inhibitor | 0.153 0.021 DBMET01434 | DBMET01434 | |
| 0.029 | 0.006 | 0.084 | Cholecystokinin A agonist | 0.084 0.004 DBMET01434 | DBMET01434 | |
| 0.026 | 0.003 | 0.037 | Glutamate (mGluR6) agonist | 0.037 0.003 DBMET01434 | DBMET01434 | |
| 0.034 | 0.013 | 0.034 | Lysine carboxypeptidase inhibitor | |||
| 0.043 | 0.023 | 0.043 | Dihydropteroate synthase inhibitor | 0.038 0.029 DBMET01434 | ||
| 0.037 | 0.016 | 0.037 | Carboxypeptidase B inhibitor | |||
| 0.047 | 0.027 | 0.047 | Carbonic anhydrase IV inhibitor | |||
| 0.056 | 0.038 | 0.056 | Carbonic anhydrase I inhibitor | |||
| 0.08 | 0.063 | 0.119 | GABA A receptor agonist | 0.119 0.024 DBMET01434 | DBMET01434 | |
| 0.033 | 0.016 | 0.04 | Purinergic P2X agonist | 0.04 0.012 DBMET01434 | DBMET01434 | |
| 0.05 | 0.033 | 0.061 | Bombesin 2 receptor antagonist | 0.061 0.024 DBMET01434 | DBMET01434 | |
| 0.055 | 0.039 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.044 | 0.028 | 0.044 | Guanylate cyclase inhibitor | |||
| 0.032 | 0.017 | 0.032 | Histone deacetylase class II inhibitor | |||
| 0.101 | 0.087 | 0.127 | Cholesterol synthesis inhibitor | 0.127 0.059 DBMET01434 | DBMET01434 | |
| 0.054 | 0.041 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.035 | 0.022 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.025 DBMET01434 | ||
| 0.063 | 0.05 | 0.063 | Matrix metalloproteinase inhibitor | |||
| 0.031 | 0.02 | 0.043 | Glucagon receptor antagonist | 0.043 0.013 DBMET01434 | DBMET01434 | |
| 0.07 | 0.059 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.034 DBMET01434 | DBMET01434 | |
| 0.036 | 0.025 | 0.036 | Arginase inhibitor | |||
| 0.017 | 0.009 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 DBMET01434 | DBMET01434 | |
| 0.019 | 0.01 | 0.019 | Angiotensin-converting enzyme 2 inhibitor | |||
| 0.187 | 0.179 | 0.221 | 5 Hydroxytryptamine uptake stimulant | 0.221 0.116 DBMET01434 | DBMET01434 | |
| 0.032 | 0.024 | 0.032 | Histone deacetylase 2 inhibitor | |||
| 0.055 | 0.047 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.04 DBMET01434 | DBMET01434 | |
| 0.027 | 0.023 | 0.027 | Histone deacetylase 10 inhibitor | |||
| 0.012 | 0.009 | 0.016 | Carbonic anhydrase XI inhibitor | 0.016 0.005 DBMET01434 | DBMET01434 | |
| 0.025 | 0.022 | 0.025 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.178 | 0.175 | 0.178 | 12-Lipoxygenase inhibitor | |||
| 0.02 | 0.019 | 0.047 | Glutamate (mGluR1a) agonist | 0.047 0.005 DBMET01434 | DBMET01434 | |
| 0.085 | 0.084 | 0.086 | Electrolyte absorption antagonist | 0.086 0.083 DBMET01434 | DBMET01434 | |
| 0.01 | 0.011 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET01434 | DBMET01434 | |
| 0.047 | 0.048 | 0.061 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.061 0.028 DBMET01434 | DBMET01434 | |
| 0.014 | 0.016 | 0.018 | Carbonic anhydrase X inhibitor | 0.018 0.01 DBMET01434 | DBMET01434 | |
| 0.014 | 0.016 | 0.018 | Carbonic anhydrase VIII inhibitor | 0.018 0.01 DBMET01434 | DBMET01434 | |
| 0.044 | 0.046 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.028 DBMET01434 | DBMET01434 | |
| 0.086 | 0.088 | 0.119 | Ferrochelatase inhibitor | 0.119 0.054 DBMET01434 | DBMET01434 | |
| 0.041 | 0.044 | 0.05 | Thromboxane A2 antagonist | 0.05 0.036 DBMET01434 | DBMET01434 | |
| 0.016 | 0.021 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 DBMET01434 | DBMET01434 | |
| 0.151 | 0.156 | 0.442 | Vasodilator | 0.442 0.017 DBMET01434 | DBMET01434 | |
| 0.054 | 0.06 | 0.085 | Ryanodine receptor antagonist | 0.085 0.007 DBMET01434 | DBMET01434 | |
| 0.018 | 0.024 | 0.023 | Lysophosphatidic acid 1 receptor antagonist | 0.023 0.012 DBMET01434 | DBMET01434 | |
| 0.065 | 0.074 | 0.084 | Somatostatin 1 agonist | 0.084 0.047 DBMET01434 | DBMET01434 | |
| 0.021 | 0.031 | 0.052 | Calcium-sensing receptor agonist | 0.052 0.005 DBMET01434 | DBMET01434 | |
| 0.032 | 0.045 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET01434 | DBMET01434 | |
| 0.042 | 0.056 | 0.052 | Aconitate hydratase inhibitor | 0.052 0.036 DBMET01434 | DBMET01434 | |
| 0.11 | 0.125 | 0.128 | Anticoagulant | 0.128 0.102 DBMET01434 | DBMET01434 | |
| 0.04 | 0.054 | 0.049 | Thromboxane antagonist | 0.049 0.042 DBMET01434 | DBMET01434 | |
| 0.032 | 0.047 | 0.039 | Purinergic P2Y antagonist | 0.039 0.037 DBMET01434 | DBMET01434 | |
| 0.035 | 0.052 | 0.044 | AICAR transformylase inhibitor | 0.044 0.031 DBMET01434 | DBMET01434 | |
| 0.038 | 0.056 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.052 0.034 DBMET01434 | DBMET01434 | |
| 0.074 | 0.093 | 0.124 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.124 0.037 DBMET01434 | DBMET01434 | |
| 0.055 | 0.076 | 0.075 | Na+ K+ transporting ATPase inhibitor | 0.075 0.056 DBMET01434 | DBMET01434 | |
| 0.035 | 0.056 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.033 DBMET01434 | DBMET01434 | |
| 0.035 | 0.059 | 0.053 | Glutamate (mGluR5) agonist | 0.053 0.023 DBMET01434 | DBMET01434 | |
| 0.045 | 0.069 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET01434 | DBMET01434 | |
| 0.015 | 0.042 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.016 DBMET01434 | DBMET01434 | |
| 0.079 | 0.109 | 0.098 | Carbonic anhydrase XV inhibitor | 0.098 0.069 DBMET01434 | DBMET01434 | |
| 0.041 | 0.072 | 0.073 | Biliverdin reductase inhibitor | 0.073 0.03 DBMET01434 | DBMET01434 | |
| 0.092 | 0.124 | 0.143 | Cathepsin H inhibitor | 0.143 0.051 DBMET01434 | DBMET01434 | |
| 0.02 | 0.061 | 0.037 | Kainate receptor antagonist | 0.037 0.032 DBMET01434 | DBMET01434 | |
| 0.071 | 0.113 | 0.109 | ABCA1 expression enhancer | 0.109 0.04 DBMET01434 | DBMET01434 | |
| 0.034 | 0.077 | 0.067 | Alcohol oxidase inhibitor | 0.067 0.03 DBMET01434 | DBMET01434 | |
| 0.05 | 0.094 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.054 DBMET01434 | DBMET01434 | |
| 0.026 | 0.073 | 0.053 | Glutamate (mGluR group I) agonist | 0.053 0.028 DBMET01434 | DBMET01434 | |
| 0.016 | 0.065 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET01434 | DBMET01434 | |
| 0.056 | 0.106 | 0.081 | Histamine N-methyltransferase inhibitor | 0.081 0.065 DBMET01434 | DBMET01434 | |
| 0.018 | 0.069 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.029 DBMET01434 | DBMET01434 | |
| 0.119 | 0.173 | 0.29 | Non-steroidal antiinflammatory agent | 0.29 0.03 DBMET01434 | DBMET01434 | |
| 0.026 | 0.084 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | 0.046 0.03 DBMET01434 | DBMET01434 | |
| 0.031 | 0.089 | 0.054 | Argininosuccinate synthase inhibitor | 0.054 0.042 DBMET01434 | DBMET01434 | |
| 0.014 | 0.075 | 0.03 | Trypsin I inhibitor | 0.03 0.025 DBMET01434 | DBMET01434 | |
| 0.029 | 0.105 | 0.059 | Purinergic P2X2 antagonist | 0.059 0.053 DBMET01434 | DBMET01434 | |
| 0.039 | 0.115 | 0.066 | Beta adrenoreceptor antagonist | 0.066 0.045 DBMET01434 | DBMET01434 | |
| 0.027 | 0.116 | 0.061 | NMDA receptor glycine site agonist | 0.061 0.045 DBMET01434 | DBMET01434 | |
| 0.044 | 0.133 | 0.079 | Ornithine decarboxylase inhibitor | 0.079 0.068 DBMET01434 | DBMET01434 | |
| 0.072 | 0.165 | 0.156 | Cyclooxygenase 3 inhibitor | 0.156 0.043 DBMET01434 | DBMET01434 | |
| 0.083 | 0.178 | 0.144 | Acetylcholine M1 receptor antagonist | 0.144 0.08 DBMET01434 | DBMET01434 | |
| 0.102 | 0.201 | 0.187 | Insulin sensitizer | 0.187 0.087 DBMET01434 | DBMET01434 | |
| 0.111 | 0.213 | 0.208 | Spasmolytic | 0.208 0.113 DBMET01434 | DBMET01434 | |
| 0.217 | 0.346 | 0.268 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.268 0.259 DBMET01434 | DBMET01434 | |
| 0.01 | 0.172 | 0.021 | Vasopressin 1 agonist | 0.021 0.016 DBMET01434 | DBMET01434 | |
| 0.053 | 0.24 | 0.107 | Microtubule formation inhibitor | 0.107 0.079 DBMET01434 | DBMET01434 | |
| 0.13 | 0.333 | 0.238 | Histamine release inhibitor | 0.238 0.165 DBMET01434 | DBMET01434 | |
| 0.009 | 0.281 | 0.034 | Somatostatin 1 antagonist | 0.034 0.031 DBMET01434 | DBMET01434 | |
| 0.059 | 0.48 | 0.216 | Hypoglycemic | 0.216 0.099 DBMET01434 | DBMET01434 | |
| 0.016 | 0.615 | 0.218 | Hypolipemic | 0.218 0.083 DBMET01434 | DBMET01434 | |
| 0.021 | 0.62 | 0.153 | Nav1.4 sodium channel blocker | 0.153 0.032 DBMET01434 | DBMET01434 | |
| 0.01 | 0.897 | 0.264 | Antiinflammatory | 0.264 0.252 DBMET01434 | DBMET01434 | |
| 0.006 | 0.947 | 0.82 | Immunomodulator | 0.82 0.004 DBMET01434 | DBMET01434 | |
| 0.003 | 0.98 | 0.2 | ErbB-2 antagonist | 0.2 0.009 DBMET01434 | DBMET01434 | |
| 0.004 | 0.995 | 0.942 | ErbB-3 antagonist | 0.942 0 DBMET01434 | DBMET01434 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |